https://www.selleckchem.com/pr....oducts/ecc5004-azd50
The patient received hematopoietic stem-cell transplantation (HSCT), after which he achieved complete remission. As of 2020-10-19, the patient's survival has exceeded 3 years, and he has returned to his normal life. A variety of factors contribute to the onset of HLH, and this case gives greater insight into the etiology of HLH. Allogeneic HSCT is a key treatment for HLH patients with underlying genetic mutations.With the popularity of neoadjuvant therapy as first-line treatment, especially for advanced squamous cell carcinoma (
Like
Comment
Share
